Circulating Nucleic Acids


ccfDNA FAQ

Top FAQs on circulating cell-free DNA (ccfDNA) analysis

Healthcare research has been moving towards finding new, noninvasive procedures – commonly referred to as “liquid biopsies” – to replace our current protocols for diagnosis and treatment monitoring. Current protocols have tended to be overly invasive, posing health risks to the patient and decreasing quality of life. This movement has been very prevalent in the… Read article →


5316_NGS_QIAseq_cfDNA_700x233

A 4-part webinar series on cfDNA in liquid biopsy

Integrated collection, stabilization and purification for the cfDNA workflow Facing challenges in your circulating cell-free DNA (cfDNA) analysis? We have everything you need to gain deep insight into cfDNA: a complete and streamlined workflow covering blood sample collection and stabilization, cfDNA isolation, sequencing analysis and data interpretation. Attend the 4-part webinar series to learn about new technologies. See… Read article →


cfDNA_Discoveries_700x233

How to optimize the preanalytical portion of your circulating cell-free DNA (cfDNA) studies

Advances in liquid biopsy are allowing new strides in studies involving circulating cell-free DNA (cfDNA). With initial use in the prenatal testing field, cfDNA began to tell its story in fetal DNA genetic testing and has offered an alternative to the invasive and risk-prone amniocentesis. Now, it is breaking barriers in the field of cancer… Read article →


FertilityPregnancy_700x233

Peer into your child’s future – medically, not astrologically!

I’ve been following noninvasive prenatal testing (NIPT) technology very closely, as QIAGEN is becoming a pioneer in providing solutions for liquid biopsy-based research. Liquid biopsy is considered by many to have great potential in the future for predictive diagnostics. Recently, I came across an interesting news article on CNN Frontiers, focusing on the scientist who first discovered… Read article →